BIOLASE INC (BIOL) Stock Price, Forecast & Analysis

NASDAQ:BIOL • US0909117022

0.129 USD
-0.02 (-13.19%)
At close: Jun 18, 2024
0.109 USD
-0.02 (-15.5%)
After Hours: 6/18/2024, 8:15:46 PM

BIOL Key Statistics, Chart & Performance

Key Statistics
Market Cap4.31M
Revenue(TTM)48.83M
Net Income(TTM)-38.26M
Shares33.39M
Float33.29M
52 Week High10.31
52 Week Low0.09
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-14.25
PEN/A
Fwd PEN/A
Earnings (Next)08-08
IPO1992-11-12
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
BIOL short term performance overview.The bars show the price performance of BIOL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

BIOL long term performance overview.The bars show the price performance of BIOL in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of BIOL is 0.129 USD. In the past month the price decreased by -19.73%. In the past year, price decreased by -98.35%.

BIOLASE INC / BIOL Daily stock chart

BIOL Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
BIOL Full Technical Analysis Report

BIOL Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to BIOL. BIOL may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
BIOL Full Fundamental Analysis Report

BIOL Financial Highlights

Over the last trailing twelve months BIOL reported a non-GAAP Earnings per Share(EPS) of -14.25. The EPS increased by 95.89% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -111.37%
ROE -14222.3%
Debt/Equity 41.66
Chartmill High Growth Momentum
EPS Q2Q%98%
Sales Q2Q%-3.21%
EPS 1Y (TTM)95.89%
Revenue 1Y (TTM)0.13%
BIOL financials

BIOL Forecast & Estimates

9 analysts have analysed BIOL and the average price target is 1.99 USD. This implies a price increase of 1441.86% is expected in the next year compared to the current price of 0.129.

For the next year, analysts expect an EPS growth of 98.59% and a revenue growth 2.98% for BIOL


Analysts
Analysts80
Price Target1.99 (1442.64%)
EPS Next Y98.59%
Revenue Next Year2.98%
BIOL Analyst EstimatesBIOL Analyst Ratings

BIOL Ownership

Ownership
Inst Owners0%
Ins Owners37.15%
Short Float %N/A
Short RatioN/A
BIOL Ownership

BIOL Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABT ABBOTT LABORATORIES19.54195.084B
ISRG INTUITIVE SURGICAL INC48.87177.398B
SYK STRYKER CORP24.65142.513B
BSX BOSTON SCIENTIFIC CORP21.62112.294B
BDX BECTON DICKINSON AND CO11.5851.988B
IDXX IDEXX LABORATORIES INC42.5750.364B
EW EDWARDS LIFESCIENCES CORP26.5445.797B
GEHC GE HEALTHCARE TECHNOLOGY16.5337.832B
RMD RESMED INC20.8737.336B
DXCM DEXCOM INC28.6228.187B

About BIOL

Company Profile

BIOL logo image BIOLASE Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Foothill Ranch, California and currently employs 188 full-time employees. BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft tissue) systems. The Waterlase brand uses a combination of water and laser energy and performs using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The firm also offers diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company also manufactures and sells consumable products and accessories for its laser systems. Its Waterlase and diode systems use disposable laser tips of differing sizes and shapes.

Company Info

BIOLASE INC

27042 Towne Centre Drive, Suite 270

Foothill Ranch CALIFORNIA 92610 US

CEO: John R. Beaver

Employees: 188

BIOL Company Website

Phone: 19493611200

BIOLASE INC / BIOL FAQ

Can you describe the business of BIOLASE INC?

BIOLASE Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Foothill Ranch, California and currently employs 188 full-time employees. BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft tissue) systems. The Waterlase brand uses a combination of water and laser energy and performs using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The firm also offers diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company also manufactures and sells consumable products and accessories for its laser systems. Its Waterlase and diode systems use disposable laser tips of differing sizes and shapes.


What is the stock price of BIOLASE INC today?

The current stock price of BIOL is 0.129 USD. The price decreased by -13.19% in the last trading session.


Does BIOL stock pay dividends?

BIOL does not pay a dividend.


What is the ChartMill rating of BIOLASE INC stock?

BIOL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


When does BIOLASE INC (BIOL) report earnings?

BIOLASE INC (BIOL) will report earnings on 2024-08-08, after the market close.